Literature DB >> 35202808

Heterogeneity of cartilage damage in Kellgren and Lawrence grade 2 and 3 knees: the MOST study.

F W Roemer1, D T Felson2, J J Stefanik3, G Rabasa2, N Wang2, M D Crema4, T Neogi2, M C Nevitt5, J Torner6, C E Lewis7, C Peloquin2, A Guermazi8.   

Abstract

OBJECTIVE: Eligibility for clinical trials in osteoarthritis (OA) is usually limited to Kellgren-Lawrence (KL) grades 2 and 3 knees. Our aim was to describe the prevalence and severity of cartilage damage in KL 2 and 3 knees by compartment and articular subregion.
DESIGN: The Multicenter Osteoarthritis (MOST) study is a cohort study of individuals with or at risk for knee OA. All baseline MRIs with radiographic disease severity KL2 and 3 were included. Knee MRIs were read for cartilage damage in 14 subregions. We determined the frequencies of no, any and widespread full-thickness cartilage damage by knee compartment, and the prevalence of any cartilage damage in 14 articular subregions.
RESULTS: 665 knees from 665 participants were included (mean age 63.8 ± 7.9 years, 66.5% women). 372 knees were KL2 and 293 knees were KL3. There was no cartilage damage in 78 (21.0%) medial tibio-femoral joint (TFJ), 157 (42.2%) lateral TFJ and 62 (16.7%) patello-femoral joint (PFJ) compartments of KL2 knees, and 17 (5.8%), 115 (39.3%) and 35 (12.0%) compartments, respectively, of KL3 knees. There was widespread full-thickness damage in 94 (25.3%) medial TFJ, 36 (9.7%) lateral TFJ and 176 (47.3%) PFJ compartments of KL2 knees, and 217 (74.1%), 70 (23.9%) and 104 (35.5%) compartments, respectively, of KL3 knees. The subregions most likely to have any damage were central medial femur (80.5%), medial patella (69.8%) and central medial tibia (69.9).
CONCLUSIONS: KL2 and KL3 knees vary greatly in cartilage morphology. Heterogeneity in the prevalence, severity and location of cartilage damage in in KL2 and 3 knees should be considered when planning disease modifying trials for knee OA.
Copyright © 2022 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage; Clinical trial; Frequency; Kellgren–Lawrence; Knee; MRI; Osteoarthritis; Radiography

Mesh:

Year:  2022        PMID: 35202808      PMCID: PMC9433455          DOI: 10.1016/j.joca.2022.02.614

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   7.507


  31 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 2.  Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.

Authors:  Win Min Oo; Shirley Pei-Chun Yu; Matthew Sean Daniel; David John Hunter
Journal:  Expert Opin Emerg Drugs       Date:  2018-12-03       Impact factor: 4.191

Review 3.  State of the Art: Imaging of Osteoarthritis-Revisited 2020.

Authors:  Frank W Roemer; Shadpour Demehri; Patrick Omoumi; Thomas M Link; Richard Kijowski; Simo Saarakkala; Michel D Crema; Ali Guermazi
Journal:  Radiology       Date:  2020-05-19       Impact factor: 11.105

4.  Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging.

Authors:  Yuqing Zhang; Michael Nevitt; Jingbo Niu; Cora Lewis; James Torner; Ali Guermazi; Frank Roemer; Charles McCulloch; David T Felson
Journal:  Arthritis Rheum       Date:  2011-03

5.  Rates and sensitivity of knee cartilage thickness loss in specific central reading radiographic strata from the osteoarthritis initiative.

Authors:  S Maschek; W Wirth; C Ladel; M-P Hellio Le Graverand; F Eckstein
Journal:  Osteoarthritis Cartilage       Date:  2014-10       Impact factor: 6.576

6.  Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.

Authors:  Marc C Hochberg; Ali Guermazi; Hans Guehring; Aida Aydemir; Stephen Wax; Patricia Fleuranceau-Morel; Asger Reinstrup Bihlet; Inger Byrjalsen; Jeppe Ragnar Andersen; Felix Eckstein
Journal:  JAMA       Date:  2019-10-08       Impact factor: 56.272

7.  Physical activity, alignment and knee osteoarthritis: data from MOST and the OAI.

Authors:  D T Felson; J Niu; T Yang; J Torner; C E Lewis; P Aliabadi; B Sack; L Sharma; A Guermazi; J Goggins; M C Nevitt
Journal:  Osteoarthritis Cartilage       Date:  2013-03-21       Impact factor: 6.576

8.  A comparison of dedicated 1.0 T extremity MRI vs large-bore 1.5 T MRI for semiquantitative whole organ assessment of osteoarthritis: the MOST study.

Authors:  F W Roemer; J A Lynch; J Niu; Y Zhang; M D Crema; I Tolstykh; G Y El-Khoury; D T Felson; C E Lewis; M C Nevitt; A Guermazi
Journal:  Osteoarthritis Cartilage       Date:  2009-09-09       Impact factor: 6.576

9.  The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.

Authors:  Hans Guehring; Flavie Moreau; Benjamin Daelken; Christoph Ladel; Oliver Guenther; Asger Reinstrup Bihlet; Wolfgang Wirth; Felix Eckstein; Marc Hochberg; Philip G Conaghan
Journal:  Semin Arthritis Rheum       Date:  2021-03-11       Impact factor: 5.532

10.  Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).

Authors:  Ali Guermazi; Jingbo Niu; Daichi Hayashi; Frank W Roemer; Martin Englund; Tuhina Neogi; Piran Aliabadi; Christine E McLennan; David T Felson
Journal:  BMJ       Date:  2012-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.